GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 83 filers reported holding GOSSAMER BIO INC in Q3 2019. The put-call ratio across all filers is 0.65 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $9,388 | -79.0% | 7,451 | -63.8% | 0.00% | – |
| Q4 2022 | $44,627 | -82.2% | 20,566 | -2.0% | 0.00% | – |
| Q3 2022 | $251,000 | +67.3% | 20,976 | +17.2% | 0.00% | – |
| Q2 2022 | $150,000 | -3.8% | 17,901 | -0.7% | 0.00% | – |
| Q1 2022 | $156,000 | -21.6% | 18,027 | +2.7% | 0.00% | – |
| Q4 2021 | $199,000 | -11.6% | 17,553 | -1.6% | 0.00% | – |
| Q3 2021 | $225,000 | +257.1% | 17,838 | +127.5% | 0.00% | – |
| Q2 2021 | $63,000 | -20.3% | 7,841 | -7.4% | 0.00% | – |
| Q1 2021 | $79,000 | -6.0% | 8,465 | -2.4% | 0.00% | – |
| Q4 2020 | $84,000 | -21.5% | 8,677 | 0.0% | 0.00% | – |
| Q3 2020 | $107,000 | -18.9% | 8,677 | -14.3% | 0.00% | – |
| Q2 2020 | $132,000 | +83.3% | 10,121 | +42.0% | 0.00% | – |
| Q1 2020 | $72,000 | -48.9% | 7,127 | -21.5% | 0.00% | – |
| Q4 2019 | $141,000 | +2.9% | 9,079 | +11.8% | 0.00% | – |
| Q3 2019 | $137,000 | +42.7% | 8,123 | +87.9% | 0.00% | – |
| Q2 2019 | $96,000 | +152.6% | 4,324 | +147.5% | 0.00% | – |
| Q1 2019 | $38,000 | – | 1,747 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 3,370,000 | $4,044,000 | 0.97% |
| Octagon Capital Advisors LP | 3,958,069 | $4,749,683 | 0.66% |
| Palo Alto Investors LP | 3,465,152 | $4,158,182 | 0.34% |
| NEA Management Company, LLC | 3,467,406 | $4,160,887 | 0.32% |
| APIS CAPITAL ADVISORS, LLC | 180,000 | $216,000 | 0.22% |
| Boxer Capital, LLC | 3,336,928 | $4,004 | 0.19% |
| HHLR ADVISORS, LTD. | 4,974,041 | $5,968,849 | 0.13% |
| Artal Group S.A. | 3,028,171 | $3,634 | 0.11% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,363,170 | $2,835,804 | 0.10% |
| Birchview Capital, LP | 99,088 | $118,906 | 0.09% |